Pharmaceuticals and the Worldwide HIV Epidemic: Can a Stakeholder Model Work?

AEI-Brookings Joint Center for Regulatory Studies

A 34-page paper arguing that the adoption of a stakeholder model by pharmaceutical companies in respect of the HIV-AIDS epidemic is likely to undermine essential R&D while doing little to curtail the epidemic

Health Posted: 2004-08-09